Osve Pharmaceutical Company was established in 1966 under the name" Iran Merck " as an joint venture between Merck and Iranian investors .

Read more

Fingolide® Fingolimod

Multiple sclerosis therapy agent, Immunomodulatory agent
Botecreel® Bosentan

Antihypertensive (pulmonary); Endothelin receptor antagonist
Erlova® Erlotinib

New generation of tyrosine kinase inhibitors in treatment of NSCLCs and Pancreatic cancers
Thalavit®

Complex of vitamins and minerals, helps thalassemic patients in growth and health statues
Oncovit ®

Complex of vitamins and minerals, helps patients undertaking chemotherapy and other types of cancer treatment regiments
Sitavix ® Sitagliptin

A dipeptyle peptidase enzyme inhibitor. Used as monotherapy or combination therapy in DM2
Sitaformin ® Metformin + Sitagliptin

A convenience use of biguanide and dipeptyle peptidase inhibitor as combination therapy in DM2
Osvimer ® 40 mg Glatiramer Acetate

New method of treatment in RRMS. Less frequents injection with the same efficacy

Product List	Poll
Gallery

Attention